An analysis of data from the COVID-19 Global Rheumatology Alliance registry shows that use of disease-modifying antirheumatic drugs or non-steroidal anti-inflammatory drugs did not increase the risk of hospitalization for COVID-19 patients with rheumatic disease, but steroid use did.
![](https://www.the-rheumatologist.org/wp-content/uploads/2020/03/covid-19-150x150.jpg)